News

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...
"Getting out the shower, I felt a tiny spot as I moisturized by body. I trusted my gut and went to get it checked out. I never could have imagined what happened next." ...
Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to ...
A new study has revealed that the drug called pembrolizumab, sold under the brand name Keytruda, not only kept head and neck ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
Nicole Golbari, a dermatological surgeon in Garden City, has a special connection with her patients because she was diagnosed ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...
"I went to a salon in Belfast every week in the summer and I even hired a sunbed to use in my house when I was 18" ...
It was after a climbing fall that Geoff Sweeney first noticed the lump. A keen boulderer, the 53-year-old was scaling a ...
RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.